• Facebook
  • Twitter
x

RealTime Images

  • Portfolio
  • About
  • Contact
  • Video
  • Blog
  • Archive
Show Navigation
Cart Lightbox Client Area

Search Results

Refine Search
Match all words
Match any word
Prints
Personal Use
Royalty-Free
Rights-Managed
(leave unchecked to
search all images)
Next
{ 532 images found }
twitterlinkedinfacebook

Loading ()...

  • November 11, 2018 - Wairoa, New Zealand - The Rocket Lab Electron booster rocket named Its Business Time, successfully lifts off from the Mahia Peninsula November 10, 2018 near Wairoa, New Zealand. The rocket carrying six small satellites is the first commercial launch for the small space start up. (Credit Image: © Kieran Fanning & Sam Toms via ZUMA Wire)
    20181111_zaa_p138_033.jpg
  • August 29, 2017 - Sao Paulo, Sao Paulo, Brazil - Model presents creation by LAB, during the Sao Paulo Fashion Week, N44 Summer 2018 edition, in Sao Paulo, Brazil. (Credit Image: © Paulo Lopes via ZUMA Wire)
    RTI20170829_zaf_l146_094.jpg
  • November 22, 2019, Pleasant Grove, Utah, U.S: Student Abigail Damielson types on a computer at Pleasant Grove High School Friday, Nov. 22, 2019, in Pleasant Grove, Utah. Alpine School District requires students taking online classes to do it during their regular schedule and in a lab. (Credit Image: © Natalie Behring/ZUMA Wire)
    20191122_znp_b190_004.jpg
  • A ‘PCR screening test’ is done in the car, outside a medical lab in Boulogne Billancourt, near Paris, France, on May 2, 2020 on 47th day of lock down to prevent the spread of the epidemic COVID-19. Photo by Ammar Abd Rabbo/ABACAPRESS.COM
    729345_004.jpg
  • A ‘PCR screening test’ is done in the car, outside a medical lab in Boulogne Billancourt, near Paris, France, on May 2, 2020 on 47th day of lock down to prevent the spread of the epidemic COVID-19. Photo by Ammar Abd Rabbo/ABACAPRESS.COM
    729345_003.jpg
  • A ‘PCR screening test’ is done in the car, outside a medical lab in Boulogne Billancourt, near Paris, France, on May 2, 2020 on 47th day of lock down to prevent the spread of the epidemic COVID-19. Photo by Ammar Abd Rabbo/ABACAPRESS.COM
    729345_002.jpg
  • A ‘PCR screening test’ is done in the car, outside a medical lab in Boulogne Billancourt, near Paris, France, on May 2, 2020 on 47th day of lock down to prevent the spread of the epidemic COVID-19. Photo by Ammar Abd Rabbo/ABACAPRESS.COM
    729345_001.jpg
  • The Duchess of Cambridge visits a Developmental Neuroscience Lab in the Psychology & Language Sciences Division at UCL, London, UK, on the 21st November 2018. Picture by Arthur Edwards/WPA-Pool. 21 Nov 2018 Pictured: Catherine, Duchess of Cambridge, Kate Middleton. Photo credit: MEGA TheMegaAgency.com +1 888 505 6342
    MEGA311638_016.jpg
  • The Duchess of Cambridge visits a Developmental Neuroscience Lab in the Psychology & Language Sciences Division at UCL, London, UK, on the 21st November 2018. Picture by Arthur Edwards/WPA-Pool. 21 Nov 2018 Pictured: Catherine, Duchess of Cambridge, Kate Middleton. Photo credit: MEGA TheMegaAgency.com +1 888 505 6342
    MEGA311638_012.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_024.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_023.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_022.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_021.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_020.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_019.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_018.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_017.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_016.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_014.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_013.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_012.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_011.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_010.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_009.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_008.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_007.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_006.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_005.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_004.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_003.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_002.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_001.jpg
  • November 20, 2018 - Chicago, IL, USA - Ziff Sistrunk, left, and Donovan Price, place crosses at Chicago Mercy Hospital to remember the shooting victims on November 20, 2018. (Credit Image: © Antonio Perez/Chicago Tribune/TNS via ZUMA Wire)
    20181120_zaf_m67_054.jpg
  • October 9, 2018 - Naperville, IL, USA - A Walgreens store in Naperville, Ill. in September 2016. Walgreens is eliminating health insurance for most eligible retirees and restricting which part-time employees qualify for paid time off as part of benefits changes. The drugstore chain also is adding a paid parental leave benefit and expanding short-term disability leaves. (Credit Image: © Genevieve Bookwalter/Chicago Tribune/TNS via ZUMA Wire)
    20181009_zaf_m67_002.jpg
  • June 14, 2018 - Detroit, MI, USA - New UAW President Gary Jones speaks during a news conference at Cobo Center in Detroit on Thursday, June 14, 2018. (Credit Image: © Ryan Garza/TNS via ZUMA Wire)
    20180614_zaf_m67_015.jpg
  • Employees carry on 500 coronavirus tests a day in the Microvida laboratory, Bravis hospital in Roosendaal, Netherlands, April 2, 2020. The number of deaths caused by an infection with the new coronavirus in the Netherlands has increased by 166 to 1,339, health authorities said on Thursday. Photo by Robin Utrecht/ABACAPRESS.COM
    726191_015.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_098.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_097.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_096.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_095.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_094.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_093.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_092.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_091.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_090.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_089.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_088.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_087.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_086.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_084.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_083.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_082.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_081.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_080.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_079.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_078.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_077.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_076.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_074.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_073.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_072.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_071.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_070.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_069.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_068.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_067.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_066.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_065.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_064.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_063.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_062.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_061.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_060.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_059.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_058.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_057.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_056.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_055.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_053.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_052.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_051.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_050.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_049.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_048.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_047.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_046.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_045.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_044.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_043.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_042.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_041.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_040.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_039.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_038.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_037.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_036.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_035.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_034.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_033.jpg
  • During the coronavirus crisis, Biosynex is the only laboratory to develop a COVID-19 screening test, on the territory of Alsace and the Northeastern, Grand Est in France. This test allows the detection of specific antibodies to the coronavirus in 10 minutes from a drop of blood. Covid-19 that appear approximately 10 to 15 days after contamination. The manufacture of this test is in progress in order to detect infected persons. Created in 2005 and based in Illkirch-Graffenstaden in Alsace, a major player in public health with more than 180 employees, the French laboratory BIOSYNEX designs, manufactures and distributes Rapid Diagnostic Tests (RDTs). April 15, 2020, in Strasbourg Northeastern, France. Photo by Nicolas Roses/ABACAPRESS.COM
    727832_032.jpg
Next